Recently, Moon Surgical announced today that its ScoPilot artificial intelligence platform, developed based on Nvidia technology, has been approved by the US FDA and will be applied to Moon Surgical's flagship product, the Maestro surgical robot.

The first AI system to achieve real-time operation during surgery
Moon Surgical was founded in 2019 as a surgical robot startup focused on developing surgical robots for laparoscopic assistance, formerly known as MastOR. It is worth mentioning that the chairman of Moon Surgical's board of directors is Dr. Frederic Moll, co-founder of Intuitive Medicine and the "father of surgical robots".

The ScoPilot artificial intelligence platform approved this time is the first AI system that can achieve real-time intraoperative operation on a commercial surgical robot platform, aiming to develop and deploy artificial intelligence (AI) based operating room (OR) applications. This platform is built on NVIDIA Holoscan technology and can provide surgeons with the following core functions through localized deployment on the Maestro system:
 Intelligent and stable field of view: automatically adjust the laparoscopic field of view to ensure that the surgical field of view is always in the best state;
 Collaborative control of instruments: Doctors can adjust the position of the laparoscope without lowering the operating instruments, maintaining surgical continuity;
 Efficiency improvement: achieving efficient operation mode of "dual handed control of three instruments"

The Maestro surgical robot is a dual arm robotic surgical assistant that can grip and operate standard laparoscopic instruments. It was approved by the FDA on June 5, 2024, with the aim of providing an easy-to-use enhanced version of traditional laparoscopic surgery for patients undergoing soft tissue surgery.
This product can provide stable retraction and camera fixation for surgeons, who always maintain control over their arms and can position them in any way they need. Its operation is simpler and easier to understand, requiring only assistance in grasping two additional instruments. Moreover, Maestro also has intraoperative camera tracking software, which will enable the camera arm to automatically follow the instruments operated by the surgeon, so as to automatically position the arm in the optimal configuration before the surgery begins.

In addition to the above advantages, the Maestro surgical robot also has a simple structure and does not require relearning; Capable of independently controlling the endoscope; Compact size; Can be used in conjunction with traditional instruments; Advantages such as low cost compared to traditional laparoscopic surgery.

Anne Osdoit, CEO of Moon Surgical, stated that ScoPilot not only enhances safety by stabilizing the field of view, but its autonomous control feature also strengthens the independence of doctors during surgery, fundamentally optimizing the operating room workflow.

AI+Medical Devices
It is worth mentioning that while Moon Surgical announced the approval of the ScoPilot artificial intelligence platform by the FDA, it also announced its next cooperation plan with Nvidia to enhance the Maestro surgical robot system through the Nvidiasaac for Healthcare platform and carry out deep technology integration, in order to achieve the following effects:
 The core architecture of digital surgery: implementing digital transformation of surgical processes through AI technology;
 Intelligent training innovation: using virtual surgical environment to generate synthetic data, replacing the traditional real surgical data training mode;
 System development acceleration: Utilizing Holoscan real-time sensing processing and IGX computing power support, accelerate the development cycle, reduce costs, and speed up time to market, while ensuring safe and effective system testing and deployment.
In recent years, as the popularity of AI continues to rise, more and more medical device companies have begun to collaborate with AI in the medical field, including medical device giants. As a leader in the field of AI computing, NVIDIA has established deep cooperation with giants such as Johnson&Johnson, Medtronic, and GE Healthcare to integrate AI technology into their products.

With the release of Isaac for Healthcare, on March 19th alone, Nvidia announced partnerships with several medical device companies, including exploring AI technology with Virtual Localization to develop the next generation of surgical robots; Expand cooperation with Neptune Medical to enhance the AI capabilities of its gastrointestinal robot system through Isaac for Healthcare; Deepen cooperation with GE Healthcare, focusing on developing independent X-ray and ultrasound applications; Strategic partnership with Hyperfine to integrate AI accelerated computing into its Swoop portable brain MRI system, among others.

Looking at the Chinese market, it can be found that China's layout for AI series has already begun. From a policy perspective, in recent years, China has also issued a series of AI medical device policies, covering regulatory, technological innovation, data security, and clinical applications, aiming to promote the high-quality development of the AI medical device industry.

Under the guidance of policies, local machinery enterprises in China are also developing towards digitalization. Among them, Mindray Medical, as a leading local medical equipment company, has partnered with Tencent AI Lab and introduced DeepSeek to launch products such as the Nuewa A20 ultrasound diagnostic system for obstetrics and gynecology.

In the future, AI, as one of the development trends, will become increasingly widespread in the medical field with continuous exploration and application.

Conclusion
The approval of ScoPilot artificial intelligence platform is expected to provide more convenient functions for Maestro surgical robots. What surprises will Moon Surgical bring in the future? Stay tuned!

Source: https://news.yaozh.com/archive/45175.html